Haleon Plc (HLN)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Ask a question about Haleon Plc (HLN)
Company Performance

Current Price

as of Oct 16, 2024

$5.00

P/E Ratio

32.53

Market Cap

$45.21B

Description

Haleon Plc engages in the provision of personal healthcare products. The firm focuses on consumer healthcare. It operates under the following geographical segments: North America, EMEA and LatAm, and Asia Pacific. The company was founded on July 18, 2022 and is headquartered in Weybridge, the United Kingdom.

Metrics

Overview

  • HQWeybridge, SU
  • SectorDistribution Services
  • IndustryMedical Distributors
  • TickerHLN
  • Price$5.003784+0.39%

Trading Information

  • Market Cap$45.21B
  • Float80.29%
  • Average Daily Volume (1m)18,884,454
  • Average Daily Volume (3m)14,131,336
  • EPS$0.11

Company

  • Revenue$11.30B
  • Rev Growth (1yr)4.09%
  • Net Income$1.05B
  • Gross Margin61.13%
  • EBITDA Margin24.90%
  • EBITDA$2.81B
  • EV$38.33B
  • EV/Revenue3.39
  • P/E32.53
  • P/S3.15
  • P/B2.12
Documents
Factset
Factset Business Description
Factset Street Account
StreetAccount Metrics Recap - Haleon Q3 Earnings (331.1000p, 0) (2023-11-02T07:16:30Z)
StreetAccount Earnings Call Q&A Summary: Haleon Q3 (321.4000p, -9.7) (2023-11-02T12:08:37Z)
StreetAccount Consensus Metrics Preview - Haleon Q3 Earnings (332.2000p, +2.7) (2023-11-01T08:53:40Z)
Questions arise about Haleon's corporate strategy - Sunday Times (321.0500p, 0) (2023-10-29T01:21:07Z)
Haleon reports Q3 net income £374M vs FactSet £317.5M [2 est, £197.2-437.7M]; FY 2023 guidance reiterated (331.1000p, 0) (2023-11-02T07:15:49Z)
Haleon reinstated buy at BofA (322.7500p, 0) (2023-11-07T07:31:51Z)
GSK intends to sell 270M ordinary shares in Haleon, equivalent to approximately 2.9% of Haleon's issued share capital. (337.0500p, 0) (2023-10-05T15:51:40Z)
Wikipedia
Haleon_plc